ANDREA HERNDON: Open Payments
NPI 1497108278 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,439 in 127 payments from 15 companies in 2025. Trend: 2023 $754 · 2024 $1,704 · 2025 $2,439
Food & beverage: $2,430Education: $9
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $468 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $429 |
| Phathom Pharmaceuticals, Inc. | 25 | $381 |
| ABBVIE INC. | 14 | $381 |
| Madrigal Pharmaceuticals | 9 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $146 |
| QOL Medical, LLC | 4 | $115 |
| Ardelyx, Inc. | 5 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $50 |
| Ipsen Biopharmaceuticals, Inc | 3 | $48 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, REZDIFFRA, SKYRIZI, ENTYVIO, Sucraid, IBSRELA.
Industry payments across KY — which companies pay providers there.
